| 标题 |
A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanoma |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Cancer Research 作者:Elena Garralda; Christoph Markert; Victor Moreno; Emiliano Calvo; Kristoffer Rohrberg; et al 出版日期:2026-04-08 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)